Large variations in the use of oral anticoagulants in stroke patients with atrial fibrillation: a Swedish national perspective
Eva‐Lotta Glader, Kjell Asplund(Umeå University), Andreas Terént(Uppsala University Hospital), P O Wester(Umeå University), Kerstin Hulter‐Åsberg(Uppsala University Hospital), Bo Norrving(Lund University), Bernd Stegmayr(Renal Association)
Cited by 42
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Priority actions for the non-communicable disease crisis
|The Lancet|2011|1.6k
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
|The Lancet Neurology|2023|731
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|616